Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+170.3%
5Y CAGR+45.8%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+170.3%/yr
vs -49.9%/yr prior
5Y CAGR
+45.8%/yr
Recent acceleration
Acceleration
+220.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
6.6x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 843.27% |
| 2024 | -114.80% |
| 2023 | 8.33% |
| 2022 | 42.68% |
| 2021 | -12.93% |
| 2020 | 127.95% |
| 2019 | -44.48% |
| 2018 | 678.30% |
| 2017 | 330.43% |
| 2016 | 80.17% |